Literature DB >> 17414255

Cognitive side effects of valproic acid-induced hyperammonemia in children with epilepsy.

Joost Nicolai, Albert P Aldenkamp, Johannes R Huizenga, Laura K Teune, Oebele F Brouwer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17414255     DOI： 10.1097/01.jcp.0000264973.77581.61

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  4 in total

Review 1.  GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.

Authors:  Meng-Yi Xu; Albert H C Wong
Journal:  Acta Pharmacol Sin       Date:  2018-03-22       Impact factor: 6.150

Review 2.  Molecular and therapeutic potential and toxicity of valproic acid.

Authors:  Sébastien Chateauvieux; Franck Morceau; Mario Dicato; Marc Diederich
Journal:  J Biomed Biotechnol       Date:  2010-07-29

3.  Initial anticonvulsant monotherapy in routine care of children and adolescents: levetiracetam fails more frequently than valproate and oxcarbazepine due to a lack of effectiveness.

Authors:  Astrid Bertsche; Martina P Neininger; Anna J Dahse; Steffen Syrbe; Matthias K Bernhard; Roberto Frontini; Wieland Kiess; Thilo Bertsche; Andreas Merkenschlager
Journal:  Eur J Pediatr       Date:  2013-08-11       Impact factor: 3.183

4.  Protective effect of rutin on impairment of cognitive functions of due to antiepileptic drugs on zebrafish model.

Authors:  Shagun Dubey; Aditya Ganeshpurkar; Divya Bansal; Nazneen Dubey
Journal:  Indian J Pharmacol       Date:  2015 Jan-Feb       Impact factor: 1.200
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.